Drug distributor Cencora has signed a definitive agreement to acquire American Oncology Network (AON), a physician-led network of more than 350 cancer care providers in 21 states, in a deal that values AON at $2.4 billion, the companies announced on Oct. 21.
For patients getting chemotherapy, infusions, or other treatment at an AON-affiliated practice, nothing changes yet. The deal still needs AON stockholder approval and regulatory clearance, and Cencora says clinical decisions will remain with AON's physicians.
